Pancreatic cancer and factors associated with the insulin resistance syndrome in the Korean cancer prevention study

Cancer Epidemiology Biomarkers and Prevention

Volumn 17, Issue 2, 2008, Pages 359-364

  De Gonzalez, Amy Berrington ^a   Ji, Eun Yun ^c   Lee, Sang Yi ^d,e   Klein, Alison P ^b   Sun, Ha Jee ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Yonsei University   (South Korea)

^d Health Insurance Policy Research Institute   (South Korea)

^e Jeju National University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

ADULT; AGED; ARTICLE; BODY MASS; CANCER INCIDENCE; CANCER PREVENTION; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; KOREA; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; METABOLIC SYNDROME X; PANCREAS CANCER; PREVENTION STUDY; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BODY MASS INDEX; FEMALE; HUMANS; INSULIN RESISTANCE; KOREA; LIPIDS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 39449096885     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-07-0507     Document Type: Article

References (32)

1. Smith SC, Jr. Multiple risk factors for cardiovascular disease and diabetes mellitus. Am J Med 2007;120:S3-11.
2. Wang F, Herrington M, Larsson J, Permert J. The relationship between diabetes and pancreatic cancer. Mol Cancer 2003;2:4.
3. Huxley R, Moghaddam AA, Berrington de Gonzalez A, Barzi F, Woodward M. Type-2 diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 2005;92:2076-83.
4. Levine W, Dyer AR, Shekelle RB, Schoenberger JA, Stamler J. Postload plasma glucose and cancer mortality in middle-aged men and women. 12-year follow-up findings of the Chicago Heart Association Detection Project in Industry. Am J Epidemiol 1990;131:254-62.
5. Balkau B, Barrett-Connor E, Eschewege E, Riachard JL, Claude JR, Ducimetiere P. Diabetes and pancreatic carcinoma. Diabetes Metab 1993;19:458-62.
6. Gapstur SM, Gann PH, Lowe W, Liu K, Colangelo L, Dyer A. Abnormal glucose metabolism and pancreatic cancer mortality. JAMA 2000;283:2552-8.
7. Batty GD, Shipley MJ, Marmot M, Smith GD. Diabetes status and post-load plasma glucose concentration in relation to site-specific cancer mortality: findings from the original Whitehall cohort study. Cancer Causes Control 2004;15:873-81.
8. Jee SH, Ohrr R, Sull JW, Yun JE, Ji M, Samet JM. Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005;293:194-202.
9. Stolzenberg-Solomon RZ, Graubard BI, Chari S, et al. Insulin, glucose, insulin resistance and pancreatic cancer in male smokers. JAMA 2005;294:2872-8.
10. Stattin P, Bjor O, Ferrari P, et al. Prospective study of hyperglycemia and cancer risk. Diabetes Care 2007;30:561-7.
11. Berrington de Gonzalez A, Sweetland S, Spencer E. Meta-analysis of obesity and the risk of pancreatic cancer. Br J Cancer 2003;89:519-23.
12. Patel AV, Rodriguez C, Bernstein L, Chao A, Thun MJ, Calle EE. Obesity, recreational physical activity, and risk of pancreatic cancer in a large U.S. cohort. Cancer Epidemiol Biomarkers Prev 2005;14:459-66.
13. Larsson SC, Permert J, Hakansson N, Naslund I, Berqkvist L, Wolk A. Overall obesity, abdominal adiposity, diabetes and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population-based cohorts. Br J Cancer 2005;93:1310-5.
14. Berrington de Gonzalez A, Spencer EA, Bueno-de-Mesquita HB, et al. Anthropometry, physical activity and the risk of pancreatic cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 2006;15:897-55.
15. Ansary Moghaddam A, Huxley R, Barzi F, et al. The effect of modifiable risk factors on pancreatic cancer mortality in populations of the Asia-Pacific region. Cancer Epidemiol Biomarkers Prev 2006;15:2435-40.
16. Reaven GM. The insulin resistance syndrome: definition and dietary approaches to treatment. Annu Rev Nutr 2005;25:391-406.
17. Jee SH, Samet JM, Ohrr R, Kim JH, Kim JS. Smoking and cancer risk in Korean men and women. Cancer Causes Control 2004;15:341-8.
18. Yun JE, Jo I, Park J, et al. Cigarette smoking, elevated fasting serum glucose, and risk of pancreatic cancer in Korean men. Int J Cancer 2006;119:208-12.
19. Cox DR. Regression models and life-tables. J R Stat Soc Series B 1972;34:187-220.
20. WHO, International Association for the Study of Obesity, International Obesity Task Force. The Asia-Pacific perspective: redefining obesity and its treatment. Sydney: Health Communications; 2000.
21. SAS statistical software version 8.0. Cary (NC): SAS Institute; 2000.
22. Hanley AJ, Williams AK, Festa A, Wagenknecht LE, D'Agostino RB, Jr., Haffner SM. Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study. Diabetes 2005;54:3140-7.
23. De Luis DA, Aller R, Izaola O, Gonzalez Sagrado M, Conde R, Gonzalez-Hernandez JM. Influence of insulin resistance in obese patients on elevated serum alanine aminotransferase. Eur Rev Med Pharmacol Sci 2007;11:21-5.
24. Miyatake N, Matsumoto S, Makino H, Numata T. Comparison of hepatic enzymes between Japanese men with and without metabolic syndrome. Acta Med Okayama 2007;61:31-4.
25. Brune K, Abe T, Canto M, et al. Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer. Am J Surg Pathol 2006;30:1067-76.
26. Andea A, Sarkar F, Adsay VN. Clinicopathological correlates of pancreatic intraepithelial neoplasia: a comparative analysis of 82 cases with and 152 cases without pancreatic ductal adenocarcinoma. Mol Pathol 2003;16:996-1006.
27. Friedman GD, van den Eeden SK. Risk factors for pancreatic cancer: an exploratory study. Int J Epidemiol 1993;22:30-7.
28. Stolzenberg-Solomon RZ, Pietinen P, Taylor PR, Virtamo J, Albanes D. A prospective study of medical conditions, anthropometry, physical activity and pancreatic cancer in male smokers. Cancer Causes Control 2002;13:417-26.
29. Lindgren AM, Nissinen AM, Tuomilehto JO, Pukkala E. Cancer pattern among hypertensive patents in North Karelia, Finland. J Hum Hypertens 2005;19:373-9.
30. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB. Cancer incidence in five continents. Vol VIII. Lyon: IARC; 2002. Scientific Publication No. 155.
31. Porta M, Malats N, Pinol JL, Rifa J, Andreu M, Real FX. Diagnostic certainty and potential for misclassification in exocrine pancreatic cancer. PANKRAS I project investigations. J Clin Epidemiol 1994;47:1069-79.
32. Verhage BAJ, Schouten LJ, Goldbohm RA, van den Brandt PA. Anthropometry and pancreatic cancer risk. Cancer Epidemiol Biomarkers Prev 2007;16:1449-54.